Prothena Corp Public (PRTA) Asset Utilization Ratio (2013 - 2026)
Prothena Corp Public's (PRTA) quarterly Asset Utilization Ratio came in at 0.17 in Q1 2026, down 35.29% year-on-year from 0.26 in Q1 2025, and up 500.72% quarter-over-quarter from 0.03 in Q4 2025.
Prothena Corp Public (PRTA) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Prothena Corp Public's Asset Utilization Ratio history runs 14 years deep, the most recent figure standing at 0.17 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 35.29% year-over-year to 0.17 in Q1 2026; TTM through Mar 2026 was 0.17, a 35.29% decrease from a year earlier, with the FY2025 full-year figure at 0.02, down 89.8% from the prior year.
- Asset Utilization Ratio climbed to 0.17 in Q1 2026 per PRTA's latest filing, from 0.03 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.34 in Q2 2024 and bottomed at 0.01 in Q3 2022.
- The 5-year median for Asset Utilization Ratio is 0.14 (2024), against an average of 0.15.
- Biggest YoY gain for Asset Utilization Ratio was 13735.08% in 2022; the steepest drop was 97.5% in 2022.
- Year by year, Asset Utilization Ratio stood at 0.08 in 2022, then surged by 54.14% to 0.13 in 2023, then soared by 86.89% to 0.24 in 2024, then slumped by 87.95% to 0.03 in 2025, then jumped by 500.72% to 0.17 in 2026.
- Per Business Quant, the three latest PRTA Asset Utilization Ratio figures stand at 0.17 (Q1 2026), 0.03 (Q4 2025), and 0.03 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.17 |
| Dec 31, 2025 | 0.03 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.26 |
| Dec 31, 2024 | 0.24 |
| Sep 30, 2024 | 0.21 |
| Jun 30, 2024 | 0.34 |
| Mar 31, 2024 | 0.14 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.37 |
| Jun 30, 2021 | 0.15 |